PortfoliosLab logoPortfoliosLab logo
BBP vs. FBT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBP vs. FBT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and First Trust Amex Biotechnology Index (FBT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBP achieves a 17.46% return, which is significantly lower than FBT's 18.66% return. Over the past 10 years, BBP has outperformed FBT with an annualized return of 11.65%, while FBT has yielded a comparatively lower 9.39% annualized return.


BBP

1D
-2.71%
1M
-5.26%
6M
15.00%
YTD
17.46%
1Y
51.33%
3Y*
19.80%
5Y*
13.17%
10Y*
11.65%
ALL TIME*
12.15%

FBT

1D
-3.01%
1M
-4.04%
6M
15.09%
YTD
18.66%
1Y
49.10%
3Y*
17.01%
5Y*
8.29%
10Y*
9.39%
ALL TIME*
13.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.01M$1.06M$1.01M
$41.36M$24.77M$18.75M

BBP vs. FBT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBP
Virtus LifeSci Biotech Products ETF
17.46%33.15%3.32%17.88%0.85%-8.17%22.24%24.73%-13.95%24.07%
FBT
First Trust Amex Biotechnology Index
18.66%24.25%5.88%2.55%-4.83%-2.26%12.96%19.74%-0.30%37.07%

Correlation

The correlation between BBP and FBT is 0.77, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.77

Correlation (3Y)
Balances recent behavior with more history.

0.80

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.84

Correlation (10Y)
Provides a long-term view across more market conditions.

0.86

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2014

0.87

The correlation between BBP and FBT shifts across timeframes, from 0.77 (1 year) to 0.87 (all time), reflecting how their relationship changes across market environments.

BBP vs. FBT - Sectors Allocation Comparison


Sectors
BBP
FBT

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

BBP
100.0%
FBT
100.0%

Basic Materials

BBP

-

FBT

-

Communication Services

BBP

-

FBT

-

Consumer Cyclical

BBP

-

FBT

-

Consumer Defensive

BBP

-

FBT

-

Energy

BBP

-

FBT

-

Financial Services

BBP

-

FBT

-

Industrials

BBP

-

FBT

-

Real Estate

BBP

-

FBT

-

Technology

BBP

-

FBT

-

Utilities

BBP

-

FBT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBP vs. FBT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BBP
BBP Risk / Return Rank: 9090
Overall Rank
BBP Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 8888
Sortino Ratio Rank
BBP Omega Ratio Rank: 8383
Omega Ratio Rank
BBP Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBP Martin Ratio Rank: 9292
Martin Ratio Rank

FBT
FBT Risk / Return Rank: 8787
Overall Rank
FBT Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
FBT Sortino Ratio Rank: 9191
Sortino Ratio Rank
FBT Omega Ratio Rank: 8888
Omega Ratio Rank
FBT Calmar Ratio Rank: 8787
Calmar Ratio Rank
FBT Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BBP vs. FBT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BBPFBTDifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

-0.22

Omega ratioGain probability vs. loss probability

1.36

1.39

-0.04

Calmar ratioReturn relative to maximum drawdown

5.61

3.47

+2.14

Martin ratioReturn relative to average drawdown

15.91

10.25

+5.66

BBP vs. FBT - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 2.20, which is comparable to the FBT Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of BBP and FBT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BBP vs. FBT - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for BBP and FBT.


Loading charts...

Drawdown Indicators


BBPFBTDifference

Max Drawdown

Largest peak-to-trough decline

-44.32%

-40.51%

-3.81%

Max Drawdown (1Y)

Largest decline over 1 year

-9.41%

-14.26%

+4.85%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

-20.05%

-6.04%

Max Drawdown (5Y)

Largest decline over 5 years

-37.77%

-28.98%

-8.79%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

-32.37%

-11.95%

Current Drawdown

Current decline from peak

-9.41%

-4.34%

-5.07%

Average Drawdown

Average peak-to-trough decline

-11.90%

-11.09%

-0.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.31%

4.81%

-1.50%

Volatility

BBP vs. FBT - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 8.02% compared to First Trust Amex Biotechnology Index (FBT) at 6.29%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBPFBTDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.02%

6.29%

+1.73%

Volatility (6M)

Calculated over the trailing 6-month period

19.16%

16.08%

+3.08%

Volatility (1Y)

Calculated over the trailing 1-year period

24.07%

21.41%

+2.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.42%

22.01%

+4.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.34%

23.77%

+3.57%

BBP vs. FBT - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than FBT's 0.57% expense ratio.


Dividends

BBP vs. FBT - Dividend Comparison

Neither BBP nor FBT has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BBP
Virtus LifeSci Biotech Products ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%
FBT
First Trust Amex Biotechnology Index
0.00%0.00%0.71%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%

Frequently Asked Questions


BBP and FBT have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBP has higher volatility (8.02%) compared to FBT (6.29%). In terms of maximum drawdown, BBP dropped -44.32% vs FBT's -40.51%.

On 10-year performance, BBP leads with 11.65% vs 9.39% for FBT. On fees, FBT is cheaper at 0.57% per year. On volatility, FBT has been the lower-risk option at 6.29%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, BBP has performed better with a 11.65% return vs 9.39%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

FBT is cheaper with a 0.57% expense ratio, compared with 0.79% for BBP.

BBP and FBT have nearly identical dividend yields, around 0.00%.

BBP tracks LifeSci Biotechnology Products Index, while FBT tracks NYSE Arca Biotechnology Index. They also come from different issuers: Virtus and First Trust. Their fees differ too: 0.79% for BBP and 0.57% for FBT.

FBT currently has the higher Sharpe Ratio (2.31 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBP and FBT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer